Stereotactic Body Radiation Therapy (SBRT) for Early-stage Lung Cancer in the Elderly

Early-stage non-small cell lung cancer (NSCLC) is on the rise due to the implementation of screening guidelines for patients at risk for developing lung cancer. It is anticipated that as the United States population continues to age, there will be a higher percentage of medically inoperable early-stage lung cancer patients. For this reason, non-invasive ablative therapies are necessary. Stereotactic body radiation therapy (SBRT) is an effective modality in addressing early-stage NSCLC. SBRT consists of high-dose radiation delivered over three to five treatments.

Source: Seminars in Oncology - July 2, 2018 Category: Cancer & Oncology Authors: Ashwin Shinde, Richard Li, Jae Kim, Ravi Salgia, Arti Hurria, Arya Amini Source Type: research